US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.00

+1.303.36%

Pre-market: 40.000.00000.00%04:00 EDT

Volume:63.45K

Turnover:2.54M

Market Cap:272.00M

PE:- -

High:40.58

Open:39.41

Low:39.41

Close:38.70

52wk High:41.49

52wk Low:22.33

Shares:6.80M

Float Shares:6.80M

Volume Ratio:0.43

T/O Rate:0.93%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Inventiva announces last patient visit in NATiV3 trial

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

Evotec, Plectonic Biotech announce immunotherapy research collaboration

Wall Street Analysts Are Bullish on Top Healthcare Picks

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Celcuity To Participate in Upcoming Investor Conferences

Moderna to Present at Morgan Stanley Global Healthcare Conference

Satellos to Participate in Upcoming Investor Conferences

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/IDNA/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":40,"timestamp":1789675200000,"preClose":38.7,"halted":0,"volume":63447,"hourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"04:00 EDT","volume":2,"amount":80,"timestamp":1789718413277,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.033591731266149796,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"Pre-Mkt","change":1.3,"latestTime":"09-18 07:51:14 EDT","open":39.41,"high":40.58,"low":39.41,"amount":2543963,"amplitude":0.030233,"askPrice":46.8,"askSize":100,"bidPrice":35.78,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":40,"sharesOutstanding":5100000,"nav":38.722209,"aum":263311021.2,"dividendRate":0.007,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"04:00 EDT","volume":2,"amount":80,"timestamp":1789718413277,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40,"preClose":40,"latestTime":"17:15 EDT","volume":203,"amount":8225.49,"timestamp":1789679712782,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4270998634880497,"impliedVol":0.275,"impliedVolPercentile":0.788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4270998634880497,"shares":6800000,"dividePrice":0.28,"high":40.58,"amplitude":0.030233,"preClose":38.7,"low":39.41,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":40,"eps":0,"divideRate":0.007,"volume":63447,"delay":0,"ttmEps":0,"open":39.41,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":37.88,"twentyDayClose":40.75,"sixtyDayClose":31.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664841533","title":"Inventiva announces last patient visit in NATiV3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841533?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:35","pubTimestamp":1788381316,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) announced the last patient has completed their final 72-week visit in the NATiV3 Phase 3 clinical trial evaluating lanifibranor for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-announces-last-patient-visit-in-nativ3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-announces-last-patient-visit-in-nativ3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVIB","HYLG","MEDX","IDNA","IVA","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664984906","title":"Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664984906","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664984906?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:31","pubTimestamp":1788381115,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Lorence H. Kim disposes of common shares worth $11.21 millionRevolution Medicines director Lorence H. Kim sold 56,000 common shares on Aug. 31 at about $200.56–$206.15.Sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1bnXL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","CANC","BBH","IE00B2B36J28.USD","IE0009355771.USD","RVMD","IDNA","IE00BJJMRZ35.SGD","LU0109394709.USD","PTH","LU0889565916.HKD","IE0009354923.USD","IE00BJT1NW94.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B894F039.SGD","MDT","LU0265550359.USD","LU0058720904.USD","BK4581","LU2089283258.USD","LU0314106906.USD","LU0106261372.USD","TBXU","LU1093756325.SGD","IE0002141913.USD","LABU","BIB","XLV","LU1778281490.HKD","LU0265550946.USD","HCSG","LU2417539215.USD","VRTX","LU2112291526.USD","LU0234570918.USD","BK4588","IDNA","LU1057294990.SGD","ALMS","LU1506573853.SGD","BK4139","IE00B19Z3B42.SGD","VERX","LU1674673691.USD","IBB","LU2023251221.USD","IE00B3T34201.USD","IE0009355771.USD","SG9999001176.SGD","LU1116320901.HKD","BBH","LU2456880835.USD","XBI","BK4533","LU0158827948.USD","LU1291159041.SGD","IE00B2B36J28.USD","PBE","GNMX","LU0162691827.USD","LU0496365809.HKD","LU1061106388.HKD","IBBQ","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890504","title":"Evotec, Plectonic Biotech announce immunotherapy research collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664890504?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:10","pubTimestamp":1788340227,"startTime":"0","endTime":"0","summary":"Evotec (EVO) and Plectonic Biotech announced a research collaboration to explore an immunotherapy approach for solid tumors. The collaboration addr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evotec-plectonic-biotech-announce-immunotherapy-research-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evotec-plectonic-biotech-announce-immunotherapy-research-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IDNA","BK4581","BK4585","EVO","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","IE00B19Z9P08.USD","LU0289739699.SGD","GNMX","IE00B4R5TH58.HKD","LU0757428866.USD","VERX","LU0109394709.USD","LU0234570918.USD","IBBQ","LU1585245621.USD","VRTX","LU2362540622.SGD","BK4533","LU0079474960.USD","XBI","BK4588","PBE","XLV","LU0029874061.USD","LU1093756325.SGD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU1674673691.USD","IE00B19Z3581.USD","LU0566484027.USD","IE00BJJMRZ35.SGD","BBH","LU2324357040.USD","LU2468319806.SGD","TBXU","IE00B2B36J28.USD","BK4581","LU0889565916.HKD","IE00B19Z3B42.SGD","BK4567","BIB","IDNA","LU1035775433.USD","LU0320765992.SGD","LU2417539215.USD","LU0432979614.USD","LU0061475181.USD","IBB","LU2456880835.USD","LABU","LU0823416689.USD","SG9999013999.USD","LU1674673428.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689541","title":"What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689541?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:23","pubTimestamp":1788315823,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals (NasdaqGS:CRNX), resulting in Crinetics becoming a wholly owned subsidiary.\nCrinetics has been delisted from the Nasdaq, with leadership changes announced as part of its integration into Vertex's operations.\nThe transaction ends Crinetics' status as an independent public company and shifts its future direction under Vertex's control.\n\nFor readers tracking consolidation in biopharma and looking for more stock ideas...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","IE0002141913.USD","LU0432979614.USD","BIB","IDNA","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4023","VRTX","LU1035775433.USD","LU0256863811.USD","LU1585245621.USD","LU2456880835.USD","IE0009355771.USD","LU2462157665.USD","LU1093756168.USD","BK4533","LU0320765992.SGD","LU2417539215.USD","PBE","TBXU","LU2362540622.SGD","IE00B4R5TH58.HKD","LU0417517546.SGD","IE00B2B36J28.USD","LU1430594728.SGD","IE00B19Z9Z06.USD","LU1674673428.USD","GNMX","BK4139","IE0002270589.USD","LU1093756325.SGD","LU2237438978.USD","BK4567","LU0234570918.USD","IE00BZ9MQY76.HKD","IBBQ","VERX","CRNX","SG9999001176.SGD","LU0061475181.USD","BBH","BK4585","SGXZ57979304.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IBB","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664743862","title":"FedEx Incheon Gateway Wins IATA CEIV Pharma Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2664743862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664743862?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:30","pubTimestamp":1788309037,"startTime":"0","endTime":"0","summary":"FedEx Incheon Gateway wins IATA CEIV Pharma certificationFedEx’s Incheon Gateway at Incheon International Airport secured IATA CEIV Pharma certification for temperature-controlled pharmaceutical air c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7spGmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","IBB","LU0251142724.SGD","IE00B19Z3B42.SGD","LU1585245621.USD","LU2089984988.USD","SGXZ57979304.SGD","BK4533","LU0432979614.USD","LU1674673691.USD","IDNA","IBBQ","LU2362541273.HKD","LU0006061336.USD","LU0061475181.USD","LU0072461881.USD","LU2237438978.USD","BK4585","HULL","LU1571399168.USD","IE0002141913.USD","SHPP","LU0058720904.USD","LU2236285917.USD","SG9999013999.USD","IE0002270589.USD","LU0109394709.USD","PBE","LU0823416689.USD","LU2456880835.USD","LU0234570918.USD","IE00B19Z3581.USD","LU1093756325.SGD","FDX","LU2417539215.USD","SG9999001176.SGD","LU1778281490.HKD","LU1267930227.SGD","LU1430594728.SGD","LU0310800965.SGD","BBH","LU1035775433.USD","BIB","BK4139","IE00B4R5TH58.HKD","TBXU","LU1069344957.HKD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486915","title":"Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486915","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486915?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:37","pubTimestamp":1788295066,"startTime":"0","endTime":"0","summary":"Moderna plans private placement of $2 billion convertible senior notes due 2032Moderna launched a private placement of USD 2 billion Convertible Senior Notes due 2032, marketed to qualified institutio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL75wNqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4551","GNOM","IDNA","BK4532","MRNY","MRNA","BK4534","BK4501","BK4548","BK4585","BK4568","BK4139","LGHT","BK4588","MRNX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0058720904.USD","IDNA","BK4534","LGHT","BK4568","BK4583","IE00B7SZLL34.SGD","TMED","LU0965508806.USD","TBXU","BK4566","BIB","LU1934455277.USD","LU2324357040.USD","BK4551","LU2112291526.USD","LU1934455863.HKD","LU1037948541.HKD","GNOM","IE00BZ1G4Q59.USD","LU1430594728.SGD","BK4588","GILD","MRNX","LU1934455194.USD","WDNA","LU1571399168.USD","BK4501","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0289739699.SGD","BBH","LU2089984988.USD","BK4533","LU0109394709.USD","BMED","LU1057294990.SGD","LU0823416689.USD","MRNA","LU1066053197.SGD","MEDI","IBBQ","LU0861579265.USD","LU2468319806.SGD","BK4139","MRNY","LU0965509010.AUD","LU0320765992.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664500918","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2664500918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664500918?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:00","pubTimestamp":1788278413,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeModerna, Inc.MRNA.OQ+6.2%Mosaic CoMOS.N+4.2%Dollar Tree IncDLTR.OQ+3.8%Corteva, Inc.CTVA.N+3.6%Dollar General CorpDG.N+3.4%Bottom PerformersPercent ChangeAxon Enterprise, Inc.AXON.OQ-9.1%CrowdStrike Holdings, Inc.CRWD.OQ-6.9%Cadence Design Systems, Inc.CDNS.OQ-5.6%Ciena CorporationCIEN.N-5.4%Palo Alto Networks, Inc.PANW.OQ-5.3%As of 12:00 p.m., the S&P 500.SPXlost 25.96 points, or 0.34%, to 7,660.18 and had posted 7 new 52-week highs and 10 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44T1PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWC","MOS","CRWL","KROP","AXUP","XAR","AIFD","CIEN","IGV","VEGI","DG","GUNZ","HAKY","LU0724618433.USD","MRNY","PANG","PANW","EYES","FOTO","AIPI","CIBR","RSPS","SPAM","XTL","PALU","CRWD","CLOD","CDNG","IHAK","AXON","PYZ","PSWD","CIEG","GNOM","FTAG","LGHT","MRNA","WCLD","WCBR","IE00B5949003.HKD","WDNA","CTVA","BUG","IDNA","DLTR","PALD","CDNS","PBJ","MRNX","CIEX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854756","title":"Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854756?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:51","pubTimestamp":1788270662,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has completed its acquisition of Crinetics Pharmaceuticals , Vertex said on Tuesday.Following the acquisition's closing, Jonathan Poole will take over Vertex's chief financial officer role, effective Jan. 1, Vertex said. Poole currently serves as Vertex's senior vice president for finance, the company said.Charles Wagner, chief operating and financial officer of Vertex, will expand his COO role to head Crinetics' integration, effective immediately, Vertex said.Price: 549.07, Change: +4.55, Percent Change: +0.83","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE00B894F039.SGD","LU0757428866.USD","LU0058720904.USD","LU2089984988.USD","LU1559883803.SGD","LU0320765992.SGD","TBXU","LU1093756325.SGD","LU2362541273.HKD","IE00B19Z9P08.USD","LU2236285917.USD","IE00BJT1NW94.SGD","BIB","LU0079474960.USD","BK4567","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU0432979614.USD","IE0002270589.USD","LU0234570918.USD","VRTX","IDNA","LU1069344957.HKD","BK4139","LU0566484027.USD","LU0823416689.USD","IE00B19Z3B42.SGD","VERX","LU1674673691.USD","CRNX","IBB","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","IE0009355771.USD","BBH","LU2456880835.USD","IE00B4R5TH58.HKD","IE00B19Z9Z06.USD","BK4533","LU0417517546.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","PBE","GNMX","LU0289739699.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144854","title":"Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144854","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144854?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:25","pubTimestamp":1788269142,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced the successful completion of the acquisition of Crinetics Pharmaceuticals (CRNX). Vertex also announced the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","IBB","LU2237438978.USD","BK4023","IE00BZ9MQY76.HKD","LU0058720904.USD","TBXU","BK4567","LU0234570918.USD","IE00B19Z3581.USD","IE00B894F039.SGD","VRTX","CRNX","LU2462157665.USD","GNMX","BBH","LU0256863811.USD","SG9999013999.USD","LU0109394709.USD","LU0320765992.SGD","LU1674673428.USD","IBBQ","LU2468319806.SGD","IE00B4R5TH58.HKD","SG9999001176.USD","BIB","LU0757428866.USD","LU1035775433.USD","LU2236285917.USD","LU1430594728.SGD","PBE","LU2362541513.USD","LU1815336091.USD","LU2089984988.USD","LU1093756168.USD","VERX","LU0823416689.USD","LU0079474960.USD","SGXZ57979304.SGD","LU0417517546.SGD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IDNA","IE0002141913.USD","IE00B2B36J28.USD","LU1093756325.SGD","IE00B19Z9P08.USD","BK4007","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0289739699.SGD","GNMX","LU1057294990.SGD","LU0109394709.USD","IE00B894F039.SGD","BK4532","LU0234570918.USD","IBBQ","GNCAQ","LU1585245621.USD","BK4139","LU1093756168.USD","VRTX","LU2362540622.SGD","SGXZ57979304.SGD","LU0079474960.USD","EVLO","BK4588","IE00B19Z9Z06.USD","PBE","LU1023059063.AUD","IE00BZ9MQY76.HKD","LU2362541273.HKD","SG9999001176.USD","LU2462157665.USD","IE0009355771.USD","BK4599","PJP","TBXU","BBH","LU2468319806.SGD","IE00B2B36J28.USD","BK4581","LU1778281490.HKD","IE00B19Z3B42.SGD","BK4566","BIB","BK4567","IE00BJT1NW94.SGD","IDNA","LU1035775433.USD","LU0432979614.USD","LU0061475181.USD","IBB","LU2089984988.USD","LU0823416689.USD","SG9999013999.USD","AMGN","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z9Z06.USD","IE0009355771.USD","VRTX","SGXZ57979304.SGD","SG9999001176.SGD","BK4585","LU2417539215.USD","IE00BZ9MQY76.HKD","LU2456880835.USD","IE00B19Z9P08.USD","IE0002141913.USD","LU2324357040.USD","LU0234570918.USD","LU2089984988.USD","IBBQ","LU1035775433.USD","IE00B894F039.SGD","BIB","LU0823416689.USD","LU2236285917.USD","LU2468319806.SGD","LU1674673691.USD","LU0417517546.SGD","LU1093756168.USD","BBH","LU1674673428.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LU0079474960.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","GNMX","LU0320765992.SGD","BK4532","BK4588","BK4139","LU1778281490.HKD","IE00BJT1NW94.SGD","IE0002270589.USD","IDNA","LU0289739699.SGD","BK4567","PBE","LU1585245621.USD","LU2237438978.USD","IE00B19Z3581.USD","IBB","TBXU","LU0432979614.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851222","title":"Celcuity To Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851222","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851222?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354143/0/en/celcuity-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIB","IDNA","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083853","title":"Moderna to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083853?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:06","pubTimestamp":1788260801,"startTime":"0","endTime":"0","summary":"Moderna to present at Morgan Stanley Global Healthcare ConferenceModerna will present at the Morgan Stanley Global Healthcare Conference on Sept. 14, 2026 at 10:00 a.m. ET.It will also present at the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8XX49W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU2023251221.USD","LU2264538146.SGD","BK4585","IAI","LU0158827948.USD","LU1989772923.USD","BK4581","LU1791710400.SGD","IE00B775SV38.USD","BK4588","GNOM","LU0267386448.USD","LU1720051017.SGD","LU0320765646.SGD","LU2347655156.SGD","LU0795875086.SGD","LU1791710582.SGD","LU0795875169.SGD","BK4501","BK4532","BK4548","LU0912757837.SGD","KBWB","LU0106831901.USD","LU1720051108.HKD","MRNA","LU0882574139.USD","MRNX","MRNY","BK4516","LGHT","LU1989772840.SGD","LU1244550577.SGD","LU0557290698.USD","LU1988902786.USD","BK4533","LU1548497426.USD","IE00BZ1G4Q59.USD","LU2028103732.USD","BK4504","LU2111349929.HKD","LU0528227936.USD","WDNA","LU2357305700.SGD","LU0390134368.USD","LU0106261372.USD","LU0225283273.USD","LU1064131342.USD","LU1732799900.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085583","title":"Satellos to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085583","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085583?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative mus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353948/0/en/satellos-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIB","IDNA","BK4139","BMED","HYLG","GDOC","MEDX","MSLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853142","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853142?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:50","pubTimestamp":1788259807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LL...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU2089984988.USD","LU2360106947.USD","LU1804176565.USD","LU2361044949.HKD","LU0964807845.USD","LU2461242641.AUD","LU2357305700.SGD","SGXZ81514606.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU2023250330.USD","IE00B7KXQ091.USD","LU0225283273.USD","LU2089284900.SGD","LU0266013472.USD","LU0672654240.SGD","LU2237443895.HKD","LU1023059063.AUD","SGXZ51526630.SGD","LU0158827781.USD","LU1974910355.USD","LU2602419157.SGD","LU0238689110.USD","LU0006306889.USD","LU2236285917.USD","IE0009355771.USD","LU2491050071.SGD","ELIL","LU2417539215.USD","LU0432979614.USD","IE00BJJMRX11.SGD","LU2491049909.HKD","PJP","LU2462591350.SGD","LU0708995401.HKD","LU2168563687.JPY","LU2750360641.GBP","SG9999014906.USD","LU0256863902.USD","LU0353189680.USD","LU0823416689.USD","IE00BK4W5L77.USD","LU2237443465.HKD","LU2265009873.SGD","LU2491050154.USD","TMED","LU2746668974.SGD","OZEM","LU0203202063.USD","LU0456855351.SGD","WDNA","LLYX","BK4007","LU0174119429.USD","LU2168564495.EUR","LU2361045086.USD","SG9999018857.SGD","LU0345770993.USD","LU0640476718.USD","LU1868837300.USD","IE00BWXC8680.SGD","LLY","LU1064131342.USD","LU0882574139.USD","LU0689472784.USD","BK4532","LU2023251221.USD","VHT","BK4533","LU0256863811.USD","LU2264538146.SGD","LU2471134879.HKD","LU1145028129.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","MHIP","IE0004445239.USD","IE00BJLML261.HKD","BK4581","LU0122379950.USD","HRTS","LU1629891620.HKD","LU0385154629.USD","LU0096364046.USD","LU2552382058.USD","LU1551013425.SGD","LU1720051108.HKD","LU0079474960.USD","LLII","LU0158827948.USD","LU2756315318.SGD","LU0882574055.USD","LU0097036916.USD","BK4139","FTXH","IE0005OL40V9.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2896262040.SGD","LU2361044865.SGD","IE00BFSS8Q28.SGD","LU0234572021.USD","SG9999001176.USD","LU2237443978.SGD","LU0354030438.USD","CANC","LU0320765059.SGD","LU1267930730.SGD","SG9999014914.USD","MEDI","LU2063271972.USD","LU1917777945.USD","LU1093756325.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU1232071149.USD","IHE","LU1989771016.USD","GDOC","IYH","LU1093756168.USD","SG9999015986.USD","SG9999014898.SGD","LU0471298694.HKD","LU2471134796.USD","LU1057294990.SGD","LU0058720904.USD","LU1291159041.SGD","LU2023250504.SGD","LU2552382132.HKD","SG9999017495.SGD","IE00B4JS1V06.HKD","SG9999015978.USD","LU0417517546.SGD","LU1551013342.USD","JDOC","ELIS","LU1548497426.USD","THNR","LU1868836757.USD","IDNA","IE00BJJMRY28.SGD","LU0786609619.USD","LU2237438978.USD","LU2471134523.USD","IE00BN29S564.USD","LU0289739699.SGD","LU0823434583.USD","IE00B2B36J28.USD","LU2213496289.HKD","TRUH","LU2028103732.USD","LU1323610961.USD","LU0345770308.USD","LU1061106388.HKD","LU2168564222.USD","LU0109394709.USD","BK4585","LU1868837136.USD","AGNG","LU0320765992.SGD","LU1988902786.USD","LU0353189763.USD","LU2468319806.SGD","SG9999015952.SGD","LU2089283258.USD","PPH","IE00BJT1NW94.SGD","LU0106261372.USD","LU0203201768.USD","LU1983299246.USD","SG9999013999.USD","LU1280957306.USD","LU0823434740.USD","LU0114720955.EUR","LU2746668461.USD","RXL","IE00B1XK9C88.USD","BK4550","IE00B775H168.HKD","LU0323591593.USD","SG9999014880.SGD","LU1035775433.USD","LU1712237335.SGD","LU2108987350.USD","LU0943347566.SGD","LU2237443622.USD","LU1868836914.USD","LU2211815571.USD","LU1868836591.USD","LU0820561818.USD","BK4588","IXJ","ILDR","SG9999018865.SGD","LU2750360997.AUD","LU2271345857.HKD","LU0061475181.USD","LU2456880835.USD","LU0787776722.HKD","LU2324357040.USD","LU2168564149.EUR","LU0354030511.USD","LU2756315664.SGD","LU1814569148.SGD","SG9999001176.SGD","IE00BK4W5M84.HKD","IE0004445015.USD","LU0683600562.USD","LU0198837287.USD","LU2237443382.USD","LU2111349929.HKD","LU1979441026.SGD","LU0133085943.USD","BK4516","LU1366192091.USD","LU2462157665.USD","LU2112291526.USD","CURE","LU1691799644.USD","IE00BFSS7M15.SGD","LU2471134952.CNY","LU2087625088.SGD","GB00BDT5M118.USD","IE0002141913.USD","MEDX","SGXZ31699556.SGD","SGXZ99366536.SGD","INCY","LU0471298777.SGD","LU2106854487.HKD","LU0109391861.USD","FHLC","LU0210536198.USD","LU0466842654.USD","IMUX","BK4599","LU0094547139.USD","IE00B4R5TH58.HKD","LU1623119135.USD","LU2552382215.SGD","SG9999015945.SGD","LLYZ","LU0316494557.USD","LU2237443549.SGD","IE0001KFT4U8.USD","LU1720051017.SGD","LU1127390331.HKD","LU0820562030.AUD","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU0320765489.SGD","CNCR","LFSC","IE00BJJMRZ35.SGD","IBBQ","PPH","BK4532","LU0070302665.USD","LU0211331839.USD","BK4588","SYNB","GDOC","IE00B2B36J28.USD","BMED","FBT","IE0009355771.USD","MEDX","NVS","IE00B4R5TH58.HKD","BK4007","IDNA","GNOM","IE00BFTCPJ56.SGD","BK4578","TBXU","LU0208291251.USD","HYLG","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664538548","title":"Revolution Medicines Signs Long-Term Headquarters Lease Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664538548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664538548?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:29","pubTimestamp":1788258558,"startTime":"0","endTime":"0","summary":"Revolution Medicines ( ($RVMD) ) has provided an announcement. On August 27, 2026, Revolution Medicines agreed to lease four buildings totaling abo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4139","IE0009354923.USD","IE00BJT1NW94.SGD","RVMD","IDNA","LU0109394709.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU0320765992.SGD","BBH","IE00B4R5TH58.HKD","PTH","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}